life science healthcare News
-
Lumosa`s CBO to Serve as Panel Judge for Innovator`s Pitch Challenge
Lumosa's Chief Business Officer, Mr. Christopher Aleong will be serving as one of the judges in the Innovator's Pitch Challenge at the RESI (Redefining Early Stage Investments) Conference, on September 21~22, 2022. The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage life science and healthcare companies to gain additional exposure to conference attendees and pitch ...
-
Edinburgh Molecular Imaging Ltd appoints new Chairman
The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans CBE CEng as non-executive Chairman with effect from 31st August 2015. In an industrial career spanning 35 years John held senior international leadership positions in global companies including Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson and Amersham plc (now GE ...
-
SymphonyAI Company TeraRecon Appoints Dan McSweeney President
Advanced visualization and AI leader TeraRecon, a SymphonyAI company, today announced the appointment of Dan McSweeney as president. He will be responsible for continuing and expanding TeraRecon's leadership in healthcare advanced visualization and enterprise AI. "TeraRecon is known for its strong reputation as the leader in advanced visualization and AI innovation in healthcare," said ...
-
Mammoth Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
Mammoth Biosciences, a biotech company building the next generation of CRISPR products to cure and detect disease, today announced its participation in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Mammoth’s co-founder and CEO, Trevor Martin, will present a corporate overview virtually on January 11, 2022 at 1:30 p.m. PT (4:30 p.m. ET). About Mammoth Biosciences Mammoth ...
-
Call for papers: OMWINDENERGY Germany 2013
OMWINDENERGY 2013, the new industry forum, invites interested parties to submit papers with a focus on "professional solutions for operation and maintenance" in the international wind sector. OMWINDENERGY Germany will be held for the first time on October 8 and 9, 2013, in Berlin. Trade fair and conference The new specialist fair and conference will be conducted in German and English. ...
-
GE Appoints Three New Company Officers
GE today announces the appointment of three new company officers. GE currently has 195 GE officers globally who lead large revenue generating businesses or are in critical functional roles, helping to drive growth. Below are the details of the new officers: Anthony J. Aiello, 47, has been named vice president Assembly, Test & Overhaul for GE Aviation. In this role, he ...
-
TeraRecon CEO Jeff Sorenson To Depart, Dr. Romesh Wadhwani To Serve As Interim CEO
TeraRecon announced today that Jeff Sorenson is stepping down from his role as chief executive officer. SymphonyAI Chairman, Dr. Romesh Wadhwani will assume the role of interim CEO while a search for a replacement CEO is underway. During his nearly 15-year tenure at TeraRecon, Sorenson was the driving force behind the company’s accelerated growth and innovation and firmly established ...
-
Qualigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO and Chairman Michael Poirier will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit September 20-23, 2021. The presentation will provide an overview of the ...
-
KLISBio to unveil cutting-edge silk-based technology platform at 2022 Digital RESI Conference
Milan, Italy (March 21, 2022) – Today, KLISBio, a MedTech company challenging the status quo in regenerative medicine by leveraging a silk-based multidisciplinary technology platform, announced its attendance 2022 Digital RESI. The conference will be held March 22-24, 2022 through a virtual platform. KLISBio’s designated attendee to Digital RESI Conference is Gabriele Grecchi, CEO ...
By KLISBio
-
Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test
Mammoth Biosciences, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its DETECTR BOOST® SARS-CoV-2 Reagent Kit, a first of its kind high-throughput solution that combines the power of CRISPR with laboratory automation for SARS-CoV-2 testing. The DETECTR BOOST platform is a turnkey, CRISPR-based molecular diagnostic ...
-
DNAnexus to Showcase Platform Scalability, Versatility, and Security at ASHG 2022 Annual Meeting
DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the speaker lineup for its customer presentations at the American Society of Human Genetics (ASHG) 2022 Annual Meeting, which is being held in Los Angeles this week. The company will also be showcasing its GxP-compliant platform and new Nextflow pipeline language ...
-
Aurora BioPharma to Attend the Oppenheimer & Co. 27th Annual Healthcare Conference at the Westin New York Grand Central in New York City
Aurora BioPharma, Inc., a clinical stage biotechnology company developing CAR T Cell Therapy to treat Solid and Liquid tumors, announced today that company CEO and President, Robert Brooks, will attend the Oppenheimer & Co. 27th Annual Healthcare Conference on March 21-22, 2017 at The Westin New York Grand Central in New York City. The event is one of the most important investor conferences ...
-
Alloy Therapeutics Raises $75 Million in Series C Financing to Advance Collaborative Biotechnology Ecosystem
Alloy Therapeutics, a biotechnology ecosystem company empowering the global scientific community to make better medicines together, today announced the close of a $75 million Series C financing round. The round was led by 8VC, Presight Capital, and Peter Thiel with participation from new investors including Mubadala Capital, the asset management arm of Mubadala Investment Company, an unnamed ...
-
Merck Files Preliminary Proxy Statement Urging Versum Shareholders to Vote Against Entegris Acquisition
Merck is convinced that the proposed Entegris acquisition is not the best option available for Versum shareholders Merck’s all-cash $48 per share proposal clearly superior to Entegris acquisition Merck, a leading science and technology company, today filed a preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC), urging all Versum shareholders to vote ...
By Siemens AG
-
ConcertAI Announces Integration of TeraRecon, Accelerating Enterprise AI Deployment into Clinical Practice and Broadening Precision Oncology Research Network
ConcertAI, LLC (ConcertAI), a leader in enterprise AI and RWD solutions for life science companies and healthcare providers, announced today the integration of TeraRecon as a ConcertAI company. The combination is unprecedented in bringing electronic medical records, genomic data, and medical image data into one integrated network and set of AI-enabled workflows that enable leading ...
-
Mammoth Biosciences Named as an “Endpoints 11” Most Promising Startup of 2022
Mammoth Biosciences, a biotech company harnessing next-generation CRISPR technology to detect and cure disease, has been chosen by Endpoints News Editor John Carroll as one of the most promising biotech startups for this year’s Endpoints 11 annual special report. Comprising a team of scientist-founders, experienced biopharma veterans, and talented researchers, Mammoth is developing a ...
-
Noleus Wins Gold Prize at Inaugural MassChallenge Houston Accelerator
MassChallenge, a global network of zero-equity startup accelerators, last night named three prize winners from its first Houston-based program: NeuroRescue, Noleous Technologies, and Sensytech. Announced at the MassChallenge Texas in Houston Finale at the House of Blues Houston, this news caps off the first-ever MassChallenge Texas in Houston program, which accelerated 25 of the world’s ...
-
Optimizing Monoclonal Antibody Production: Temperature And Osmolality’s Impact, Upcoming Webinar Hosted By Xtalks
In this free webinar sponsored by Advanced Instruments, gain insights into advances in monoclonal antibody production technology and manufacturing strategies. Attendees will learn why temperature and osmolality in cell culture are critical parameters affecting cell growth, viability and the concentration of HCPs in the supernatant. The featured speaker will discuss how temperature and osmolality ...
-
Optibrium strengthens global AI drug discovery software operations with three key appointments
Michelle Harrison appointed as Head of Strategic Marketing; Chris Khoury and Imran Ghauri join to boost Optibrium’s business development team. UK and US-based appointments with proven AI and life science expertise will support the next phase of commercial growth for Optibrium’s computational drug discovery technologies. Optibrium, a leading developer of software and artificial ...
-
Orchestra BioMed Secures $20 Million Financing Facility from Silicon Valley Bank
Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, today announced that it has entered into a $20 million credit facility agreement with Silicon Valley Bank (SVB), the bank of the world’s most innovative companies and their investors. This ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you